Regulation of mammalian target of rapamycin complex 1 by Bcl-2 and Bcl-XL proteins.
J Biol Chem
; 288(40): 28824-30, 2013 Oct 04.
Article
em En
| MEDLINE
| ID: mdl-23960074
Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth and metabolism. Its activity is controlled by various types of signals, including growth factors, nutrients, and stresses. In this study, we show that changes in expression levels of two antiapoptotic proteins, Bcl-2 and Bcl-XL, also affect mTORC1 signaling activity. In cells overexpressing Bcl-XL, mTORC1 activity is increased and becomes less sensitive to growth factor or nutrient conditions. In contrast, reduction in expression levels of the two antiapoptotic proteins inhibits mTORC1 signaling activity. Our results suggest that the effect of Bcl-2 and Bcl-XL on mTORC1 is mediated by FKBP38, an inhibitor of mTORC1. The two proteins compete with mTORC1 for FKBP38 binding and hence alter mTORC1 activity. This study reveals a novel cross-talk between Bcl-2/XL and mTORC1 signaling, which is likely to contribute to cancer development.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Complexos Multiproteicos
/
Proteína bcl-X
/
Serina-Treonina Quinases TOR
Limite:
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article